Apple’s visionary founder, the late Steve Jobs once said, “the biggest innovations of the 21st century will be at the intersection of biology and technology”.
And that prediction is coming true in the drug discovery field where biology, nanotechnology and AI are uniting against previously untreatable diseases, pandemics, and human ageing.
“Out of COVID’s death and devastation and the knock-on effect upon people already weakened by cancers, heart disease and other long-term killers, it is uplifting to see how the biotech, nanomedicine and computing disciplines are responding,” said Paul Stannard, chairman of the healthcare charity World Science Aid and the World Nano Foundation – the not-for-profit that supports global commercialisation of nanotechnology.
“It’s a combination that Steve Jobs forecast with such typical vision and has already given us faster and more effective vaccine production and virus testing to push back against COVID, while starting to map out more effective health systems that major on treatment at the point of care.
“But real excitement comes from new drug discovery techniques, spearheaded by powerful computing and artificial intelligence platforms that Steve Jobs would have picked out to be disruptors just like his iMac, iPod and iPad.”
As an example, Stannard highlighted developments at a small but fast-growing Silicon Valley neighbour to Jobs’ giant Apple Inc, the AI-driven drug discovery company Verseon, which has built a proprietary technology platform to create new drugs atom by atom.
Fremont-based Verseon says the platform is far more sophisticated than the ‘AI systems’ of other drug developers, as it enables the design of the entirely new chemical structures needed to fight currently untreatable diseases.
Biology, nanotechnology and AI combined could revolutionise modern healthcare and disease & pandemic protection.
Verseon stresses that AI is only as effective as the data available for it to learn from, as shown by issues arising from development of ‘self-driving’ vehicles; in the case of other ‘AI drug discovery systems’ this data comes only from existing drugs and past experiments.
As highlighted by current coverage in Impact Wealth Magazine, Verseon has freed itself from that conventional approach and is bringing much-needed new treatments to market for cancers, heart disease, and other killers. The company is also developing products that slow human aging and boost longevity.
Many market watchers now believe that despite the pharmaceutical industry’s $1 trillion a year patent-protected revenue, its failure-prone trial-and-error drug development process is an increasing impediment to finding badly needed disease treatments.
Verseon realized that systematic design of completely new drugs requires breakthroughs in molecular-physics modeling to determine how a new chemical structure will bind to a disease-causing protein.
And using its platform, the company has identified multiple new clinical candidates for every one of its programs – a feat unheard of in the pharmaceutical industry.
Verseon’s management team holds over 200 patents collectively and are no strangers to transformational breakthroughs.
Co-founders Adityo Prakash (CEO) and Eniko Fodor (COO) patented technologies now owned by Intel that power all video streaming today, from Amazon Prime to Zoom.
Adityo Prakash, CO-Founder and CEO of Verseon.
The third Verseon Co-founder, Chief Science Officer (CSO) David Kita developed one of the first bioinformatics platforms that catalyzed the genomics revolution.
And Verseon’s Chief Technical Officer Sangtae Kim – a former CEO at the influential Morgridge Institute biomedical unit, and a former VP at major pharma company, Eli Lilly – is now driving enhancement of the company’s powerful AI.
“Verseon’s platform comprises significant new advances within multiple distinct branches of science,” he said.
“Any one of these advances would be enthusiastically welcomed by leading practitioners in their respective domains but collecting them together is virtually unattainable by any other organization. It is by far the most advanced ab initio drug design methodology currently in existence.”
Verseon is already trialling drugs to treat and prevent heart attacks and strokes.
John Deanfield, University College London Professor of Cardiology.
Verseon is currently trialling drugs with remarkably low bleeding risk to treat and prevent heart attacks and strokes in over 400 million patients worldwide – uncontrolled bleeding is the biggest risk factor with current alternatives.
One of the world’s leading cardiologists John Deanfield, University College London’s Professor of Cardiology, commented:
Robert Karr, former SVP of R&D Strategy
“Verseon’s platelet-sparing anticoagulants…represent an exciting ‘precision medicine’ opportunity for the treatment of a large population of cardiovascular disease patients.”
Verseon is also developing oral drugs to treat diabetic vision loss in over 154 million patients, plus a cure for coronaviruses, and three different programs to fight cancer – one of the world’s biggest killers.
All of these are part of a fast-growing drug pipeline of 16 candidate drugs across eight programs, including cancers, heart disease, and degenerative eye diseases due to diabetes.
Pfizer’s former SVP of R&D Strategy Robert Karr said: “Verseon’s disruptive platform changes how drugs can be discovered and developed, and the company is poised to make a dramatic impact on modern medicine.”
News
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D at unprecedented resolution using X-rays, non-destructively. The breakthrough overcomes a long-standing technological barrier that had limited [...]
Scientists Uncover Hidden Blood Pattern in Long COVID
Researchers found persistent microclot and NET structures in Long COVID blood that may explain long-lasting symptoms. Researchers examining Long COVID have identified a structural connection between circulating microclots and neutrophil extracellular traps (NETs). The [...]
This Cellular Trick Helps Cancer Spread, but Could Also Stop It
Groups of normal cbiells can sense far into their surroundings, helping explain cancer cell migration. Understanding this ability could lead to new ways to limit tumor spread. The tale of the princess and the [...]
New mRNA therapy targets drug-resistant pneumonia
Bacteria that multiply on surfaces are a major headache in health care when they gain a foothold on, for example, implants or in catheters. Researchers at Chalmers University of Technology in Sweden have found [...]
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
Scientists Identify the Evolutionary “Purpose” of Consciousness
Summary: Researchers at Ruhr University Bochum explore why consciousness evolved and why different species developed it in distinct ways. By comparing humans with birds, they show that complex awareness may arise through different neural architectures yet [...]
Novel mRNA therapy curbs antibiotic-resistant infections in preclinical lung models
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. The findings, published in Nature Biotechnology, show that in [...]
New skin-permeable polymer delivers insulin without needles
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections. A recent study published in the journal Nature examines [...]
Multifunctional Nanogels: A Breakthrough in Antibacterial Strategies
Antibiotic resistance is a growing concern - from human health to crop survival. A new study successfully uses nanogels to target and almost entirely inhibit the bacteria P. Aeruginosa. Recently published in Angewandte Chemie, the study [...]
Nanoflowers rejuvenate old and damaged human cells by replacing their mitochondria
Biomedical researchers at Texas A&M University may have discovered a way to stop or even reverse the decline of cellular energy production—a finding that could have revolutionary effects across medicine. Dr. Akhilesh K. Gaharwar [...]
The Stunning New Push to Protect the Invisible 99% of Life
Scientists worldwide have joined forces to build the first-ever roadmap for conserving Earth’s vast invisible majority—microbes. Their new IUCN Specialist Group reframes conservation by elevating microbial life to the same urgency as plants and [...]
Scientists Find a Way to Help the Brain Clear Alzheimer’s Plaques Naturally
Scientists have discovered that the brain may have a built-in way to fight Alzheimer’s. By activating a protein called Sox9, researchers were able to switch on star-shaped brain cells known as astrocytes and turn them into [...]
Vision can be rebooted in adults with amblyopia, study suggests
Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic eye, new research shows. In the common vision [...]
Ultrasound-activated Nanoparticles Kill Liver Cancer and Activate Immune System
A new ultrasound-guided nanotherapy wipes out liver tumors while training the immune system to keep them from coming back. The study, published in Nano Today, introduces a biodegradable nanoparticle system that combines sonodynamic therapy and cell [...]
